Brighton Jones’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
Brighton Jones's ALT Position: Q3 2026 in Review
Brighton Jones sold out of Altimmune (ALT) in Q3 2026, closing a stake of 12,596 shares — an estimated $38.3K sold.
Brighton Jones first reported a position in ALT in Q2 2026 and held it in 1 quarter. The position peaked at $38.3K in Q2 2026. 147 funds tracked by Wall St. Rank hold ALT as of Q3 2026.
- Brighton Jones reported no remaining Altimmune position as of Q3 2026 after selling out during the quarter.
- Brighton Jones sold 12,596 Altimmune shares in Q3 2026, an estimated $38.3K.
- Brighton Jones first reported a position in Altimmune in Q2 2026 and held it in 1 quarter.
- Brighton Jones's Altimmune position peaked at $38.3K in Q2 2026.
- 147 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.